Tandem Diabetes Care Announces Upcoming Conference Presentations [Yahoo! Finance]
Tandem Diabetes Care Announces Upcoming Conference Presentations
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) had its price target raised by analysts at Barclays PLC from $58.00 to $60.00. They now have an "overweight" rating on the stock.
TNDM Q3 Earnings Beat, '24 Sales View Up, Stock Falls in Aftermarket [Yahoo! Finance]
Analyst Estimates: Here's What Brokers Think Of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) After Its Third-Quarter Report [Yahoo! Finance]